Just for some clairity

The interposer die platform itself has gone through the qualification and reliability cycling at Denselight and the tech has been transfered to Silterra for large wafer production. Each downstream interposer assembly has to be customer tested, not because of the platform, but because of the inclusion of customer hardware and their unique requirements.

This may be why the transceiver work is also now being accelerated. With the complete unit, less testing time is required because it is a complete, one time test unit. Much less time and money than testing stand alone ROE, TOE, mux and demux units.

Two things of importance about this. As Suresh pointed out during the questions, the onus is on PoET to prove the measure, and carry the cost of their initial 2nd generation 100G offerings using the platform. From what little we have to go on, it appears that Almae has a prototype up and that cycling and qualification is already in the works and cost accounted for. The second thing is that on the 400G developmental side, cost sharing and NRE funds will be available as clients find they really like the what the interposer offers and want a front row seat for 400G products.

So, realistically, 100G related volume orders can be expected in first 1/2 of 2019 and larger NRE fees and/or partnering arrangements should also show up late in the first half of 2019.

There appears to be no question that further liquidity is required. Denselight's in house product revenue streams seem stable for now, so perhaps these other revenue streams are what Mika hopes will lift the SP and woo some of us warrant holders to convert.

Gutsy, risky, but possible.

IMO, of course